| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |